Effects of the trace amine associated receptor 1 agonist RO5263397 on abuse-related behavioral indices of methamphetamine in rats

International Journal of Neuropsychopharmacology

Volumn 18, Issue 4, 2014, Pages 1-7

  Jing, Li ^a,b   Zhang, Yanan ^c   Li, Jun Xu ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b TIANJIN MEDICAL UNIVERSITY   (China)

^c RTI INTERNATIONAL   (United States)

Author keywords

Methamphetamine; Rats; Reinstatement; Self administration; TAAR 1

Indexed keywords

AMINE; DRUGS USED IN THE TREATMENT OF ADDICTION; G PROTEIN COUPLED RECEPTOR; METHAMPHETAMINE; RO 5263397; TRACE AMINE ASSOCIATED RECEPTOR 1; UNCLASSIFIED DRUG; 4-(3-FLUORO-2-METHYLPHENYL)-4,5-DIHYDROOXAZOL-2-YLAMINE; CENTRAL STIMULANT AGENT; OXAZOLE DERIVATIVE; SUGAR INTAKE; TRACE AMINE-ASSOCIATED RECEPTOR 1;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASSOCIATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG SEEKING BEHAVIOR; DRUG SELF ADMINISTRATION; LOCOMOTION; MALE; METHAMPHETAMINE DEPENDENCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REINFORCEMENT; SENSITIZATION; ADMINISTRATION AND DOSAGE; AGONISTS; AKATHISIA, DRUG-INDUCED; AMPHETAMINE DEPENDENCE; ANIMAL; BEHAVIOR, ADDICTIVE; DRUG EFFECTS; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT; SUGAR INTAKE;

AKATHISIA, DRUG-INDUCED; AMPHETAMINE-RELATED DISORDERS; ANIMALS; BEHAVIOR, ADDICTIVE; CENTRAL NERVOUS SYSTEM STIMULANTS; CUES; DIETARY SUCROSE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG-SEEKING BEHAVIOR; MALE; METHAMPHETAMINE; OXAZOLES; RATS, SPRAGUE-DAWLEY; RECEPTORS, G-PROTEIN-COUPLED; SELF ADMINISTRATION;

EID: 84924351643     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1093/ijnp/pyu060     Document Type: Article

References (27)

1. Achat-Mendes C, Lynch LJ, Sullivan KA, Vallender EJ, Miller GM (2012) Augmentation of methamphetamine-induced behaviors in transgenic mice lacking the trace amine-associated receptor 1. Pharmacol Biochem Behav 101:201-207.
2. An XF, Zhang Y, Winter JC, Li JX (2012) Effects of imidazoline I(2) receptor agonists and morphine on schedule-controlled responding in rats. Pharmacol Biochem Behav 101:354-359.
3. Borders TF, Booth BM, Han X, Wright P, Leukefeld C, Falck RS, Carlson RG (2008) Longitudinal changes in methamphetamine and cocaine use in untreated rural stimulant users: racial differences and the impact of methamphetamine legislation. Addiction 103:800-808.
4. Borowsky B, Adham N, Jones KA, Raddatz R, Artymyshyn R, Ogozalek KL, Durkin MM, Lakhlani PP, Bonini JA, Pathirana S, Boyle N, Pu X, Kouranova E, Lichtblau H, Ochoa FY, Branchek TA, Gerald C (2001) Trace amines: identification of a family of mammalian G protein-coupled receptors. Proc Natl Acad Sci USA 98:8966-8971.
5. Bossert JM, Marchant NJ, Calu DJ, Shaham Y (2013) The reinstatement model of drug relapse: recent neurobiological findings, emerging research topics, and translational research. Psychopharmacology 229:453-476.
6. Bunzow JR, Sonders MS, Arttamangkul S, Harrison LM, Zhang G, Quigley DI, Darland T, Suchland KL, Pasumamula S, Kennedy JL, Olson SB, Magenis RE, Amara SG, Grandy DK (2001) Amphetamine, 3, 4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor. Molecular Pharmacol 60:1181-1188.
7. Chesworth R, Brown RM, Kim JH, Lawrence AJ (2013) The metabotropic glutamate 5 receptor modulates extinction and reinstatement of methamphetamine-seeking in mice. PloS ONE 8:e68371.
8. Crawford JT, Roberts DC, Beveridge TJ (2013) The group II metabotropic glutamate receptor agonist, LY379268, decreases methamphetamine self-administration in rats. Drug Alcohol Depend 132:414-419.
9. Ferragud A, Velazquez-Sanchez C, Canales JJ (2014) Modulation of methamphetamine's locomotor stimulation and selfadministration by JHW 007, an atypical dopamine reuptake blocker. Eur J Pharmacol 731:73-79.
10. Grandy DK (2007) Trace amine-associated receptor 1-Family archetype or iconoclast? Pharmacol Ther 116:355-390.
11. Karila L, Weinstein A, Aubin HJ, Benyamina A, Reynaud M, Batki SL (2010) Pharmacological approaches to methamphetamine dependence: a focused review. Br J Clinical Pharmacol 69:578-592.
12. Li JX (2014) Trace amines and cocaine abuse. ACS chemical neuroscience 5:497-498.
13. Lindemann L, Meyer CA, Jeanneau K, Bradaia A, Ozmen L, Bluethmann H, Bettler B, Wettstein JG, Borroni E, Moreau JL, Hoener MC (2008) Trace amine-associated receptor 1 modulates dopaminergic activity. J Pharmacol Exp Ther 324:948-956.
14. Miller GM (2011) The emerging role of trace amine-associated receptor 1 in the functional regulation of monoamine transporters and dopaminergic activity. J Neurochem 116:164-176.
15. Newman AH, Blaylock BL, Nader MA, Bergman J, Sibley DR, Skolnick P (2012) Medication discovery for addiction: translating the dopamine D3 receptor hypothesis. Biochem Pharmacol 84:882-890.
16. Ohmori T, Abekawa T, Koyama T (1996) The role of glutamate in behavioral and neurotoxic effects of methamphetamine. Neurochem Intl 29:301-307.
17. Pei Y, Lee J, Leo D, Gainetdinov RR, Hoener MC, Canales JJ (2014) Activation of the trace amine-associated receptor 1 prevents relapse to cocaine seeking. Neuropsychopharmacology (epub).
18. Revel FG, Moreau JL, Gainetdinov RR, Bradaia A, Sotnikova TD, Mory R, Durkin S, Zbinden KG, Norcross R, Meyer CA, Metzler V, Chaboz S, Ozmen L, Trube G, Pouzet B, Bettler B, Caron MG, Wettstein JG, Hoener MC (2011) TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity. Proc Natl Acad Sci USA 108:8485-8490.
19. Revel FG, Moreau JL, Pouzet B, Mory R, Bradaia A, Buchy D, Metzler V, Chaboz S, Groebke Zbinden K, Galley G, Norcross RD, Tuerck D, Bruns A, Morairty SR, Kilduff TS, Wallace TL, Risterucci C, Wettstein JG, Hoener MC (2013) A new perspective for schizophrenia: TAAR1 agonists reveal antipsychotic- and antidepressant-like activity, improve cognition and control body weight. Mol Psychiatry 18:543-556.
20. Simon SL, Domier CP, Sim T, Richardson K, Rawson RA, Ling W (2002a) Cognitive performance of current methamphetamine and cocaine abusers. J Addict Dis 21:61-74.
21. Simon SL, Richardson K, Dacey J, Glynn S, Domier CP, Rawson RA, Ling W (2002b) A comparison of patterns of methamphetamine and cocaine use. J Addict Dis 21:35-44.
22. Steketee JD, Kalivas PW (2011) Drug wanting: behavioral sensitization and relapse to drug-seeking behavior. Pharmacol Rev 63:348-365.
23. Thorn DA, Zhang C, Zhang Y, Li JX (2014a) The trace amine associated receptor 1 agonist RO5263397 attenuates the induction of cocaine behavioral sensitization in rats. Neuroscience Lett 566:67-71.
24. Thorn DA, Jing L, Qiu Y, Gancarz-Kausch AM, Galuska CM, Dietz DM, Zhang Y, Li JX (2014b) Effects of the trace amine-associated receptor 1 agonist ro5263397 on abuse-related effects of cocaine in rats. Neuropsychopharmacology 39:2309-2316.
25. Verrico CD, Haile CN, Newton TF, Kosten TR, De La Garza R 2nd (2013) Pharmacotherapeutics for substance-use disorders: a focus on dopaminergic medications. Expert Opin Investig Drugs 22:1549-1568.
26. Xie Z, Miller GM (2009) Trace amine-associated receptor 1 as a monoaminergic modulator in brain. Biochem Pharmacol 78:1095-1104.
27. Zhang Y, Loonam TM, Noailles PA, Angulo JA (2001) Comparison of cocaine- and methamphetamine-evoked dopamine and glutamate overflow in somatodendritic and terminal field regions of the rat brain during acute, chronic, and early withdrawal conditions. Ann N Y Acad Sci 937:93-120.